China's IVD market maintains a strong momentum driven by the country's large population, aging society and people's increasing healthcare expenditure. Imported products remain robust in upstream and high-end market. From 2019 to 2022, U.S. exports to China have reported steadfast growth in major categories, such as blood products (HS3002), reagents (HS3822), medical and surgical devices (HS9018) and analytical devices (HS9027).
This webinar will provide you with valuable insights into the latest trends, opportunities, and challenges in this dynamic industry. We've assembled a panel of insiders who will share their knowledge and expertise on key aspects. You'll gain a deep understanding of the regulatory landscape and market entry strategies.